Results: There were significant differences among HerbaLeonuri Preparations from different pharmaceutical factories, place of origin and batches.
结果:不同厂家、产地、批号的益母草制剂,含量差异显著达不到部颁标准要求。
2
Objective to observe the genetic toxicity and anti-mutation effect of HerbaLeonuri.
目的观察中药益母草的遗传毒性和抗诱变作用。
3
Objective to set up the thin-layer chromatogram differentiation method of the principal ingredients in compound HerbaLeonuri particle, and to establish the foundation for the quality control stander.